US5977144A
(en)
*
|
1992-08-31 |
1999-11-02 |
University Of Florida |
Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
|
AR013184A1
(es)
*
|
1997-07-18 |
2000-12-13 |
Astrazeneca Ab |
Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
|
US6277870B1
(en)
*
|
1998-05-04 |
2001-08-21 |
Astra Ab |
Use
|
SE9900100D0
(sv)
|
1999-01-15 |
1999-01-15 |
Astra Ab |
New compounds
|
JP4564135B2
(ja)
*
|
1999-07-26 |
2010-10-20 |
住友化学株式会社 |
高純度フェノチアジン化合物とその製造方法、およびその中間体の製造方法、並びにその中間体の原料の水和物と新規結晶
|
WO2001066546A1
(fr)
*
|
2000-03-09 |
2001-09-13 |
Mitsubishi Pharma Corporation |
Composes spiro, leur procede de preparation et leur utilisation comme medicaments
|
US8914114B2
(en)
|
2000-05-23 |
2014-12-16 |
The Feinstein Institute For Medical Research |
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
|
EP1317460A4
(en)
*
|
2000-08-28 |
2005-04-20 |
Univ Colorado State Res Found |
COMPOUNDS CONTAINING OXAZOLIDINONE FRAGMENT AND USES
|
US6569865B2
(en)
|
2001-06-01 |
2003-05-27 |
Astrazeneca Ab |
Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
|
US20040259909A1
(en)
*
|
2001-10-16 |
2004-12-23 |
Mccarthy Dennis |
Treatment of fibromyalgia syndrome
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
JP2005522457A
(ja)
*
|
2002-02-26 |
2005-07-28 |
ノース ショア−ロング アイランド ジューイッシュ リサーチ インスティチュート |
脳ムスカリン性レセプターの刺激による炎症性サイトカイン産生の阻害
|
SE0202598D0
(sv)
*
|
2002-09-02 |
2002-09-02 |
Astrazeneca Ab |
Alpha-7 Nicotinic receptor agonists and statins in combination
|
ES2293086T3
(es)
*
|
2002-12-06 |
2008-03-16 |
The Feinstein Institute For Medical Research |
Inhibicion de la inflamacion usando agonistas colinergicos de union al receptor alfa 7.
|
US7238715B2
(en)
*
|
2002-12-06 |
2007-07-03 |
The Feinstein Institute For Medical Research |
Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
|
BRPI0412382A
(pt)
*
|
2003-07-08 |
2006-09-19 |
Astrazeneca Ab |
composto , método para a verificação de novos compostos medicinais que se ligam a e modulam a atividade, por agonismo , agonismo parcial, ou antagonismo, do receptor de acetilcolina nicotìnico alfa7, método de tratamento ou profilaxia de uma doença ou condição humana, método para tratamento de jetlag, induzindo interrupção de fumar, vìcio em nicotina, abstinência, dor, e para colite ulcerativa, composição farmacêutica, e, método de tratamento ou prevenção de uma condição ou distúrbio que surge da disfunção de neurotransmissão do receptor de acetilcolina nicotìnico em um mamìfero, e, uso de um composto
|
US10912712B2
(en)
|
2004-03-25 |
2021-02-09 |
The Feinstein Institutes For Medical Research |
Treatment of bleeding by non-invasive stimulation
|
JP2007530586A
(ja)
|
2004-03-25 |
2007-11-01 |
ザ ファインスタイン インスティテュート フォー メディカル リサーチ |
神経性止血法
|
JP2008524208A
(ja)
*
|
2004-12-15 |
2008-07-10 |
アストラゼネカ・アクチエボラーグ |
ニコチン性アセチルコリン受容体リガンド
|
US11207518B2
(en)
|
2004-12-27 |
2021-12-28 |
The Feinstein Institutes For Medical Research |
Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
|
ATE489132T1
(de)
|
2004-12-27 |
2010-12-15 |
The Feinstein Inst Medical Res |
Behandlung von entzündlichen erkrankungen durch elektrische stimulation des vagus-nervs
|
EP1833804A1
(en)
*
|
2004-12-28 |
2007-09-19 |
AstraZeneca AB |
Aryl sulphonamide modulators
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス,インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
US8316104B2
(en)
|
2005-11-15 |
2012-11-20 |
California Institute Of Technology |
Method and apparatus for collaborative system
|
WO2008028903A2
(en)
|
2006-09-04 |
2008-03-13 |
Neurosearch A/S |
Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
|
US7998971B2
(en)
|
2006-09-08 |
2011-08-16 |
Braincells Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
WO2009029614A1
(en)
|
2007-08-27 |
2009-03-05 |
The Feinstein Institute For Medical Research |
Devices and methods for inhibiting granulocyte activation by neural stimulation
|
DE102008015999B4
(de)
|
2008-03-27 |
2011-04-21 |
Novar Gmbh |
Übertragungsweg - Prüfverfahren für eine Gefahrenmeldeanlage
|
US9211409B2
(en)
*
|
2008-03-31 |
2015-12-15 |
The Feinstein Institute For Medical Research |
Methods and systems for reducing inflammation by neuromodulation of T-cell activity
|
US9662490B2
(en)
|
2008-03-31 |
2017-05-30 |
The Feinstein Institute For Medical Research |
Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
EA201001889A1
(ru)
|
2008-06-20 |
2011-08-30 |
Астразенека Аб |
Производные дибензотиазепина и их применение
|
AU2009316801C1
(en)
|
2008-11-18 |
2015-12-24 |
Setpoint Medical Corporation |
Devices and methods for optimizing electrode placement for anti-inflammatory stimulation
|
TR201807944T4
(tr)
|
2008-11-19 |
2018-06-21 |
Forum Pharmaceuticals Inc |
(R)-7-kloro-N-(kinüklidin-3-il)benzo[b]tiyofen-2-karboksamit ve bunun farmasötik olarak kabul edilebilir tuzları ile şizofreninin negatif belirtilerinin tedavisi.
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
US9211410B2
(en)
|
2009-05-01 |
2015-12-15 |
Setpoint Medical Corporation |
Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
|
US8788034B2
(en)
|
2011-05-09 |
2014-07-22 |
Setpoint Medical Corporation |
Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
|
US8996116B2
(en)
|
2009-10-30 |
2015-03-31 |
Setpoint Medical Corporation |
Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
|
US8886339B2
(en)
|
2009-06-09 |
2014-11-11 |
Setpoint Medical Corporation |
Nerve cuff with pocket for leadless stimulator
|
JP5808319B2
(ja)
*
|
2009-05-11 |
2015-11-10 |
フォルム ファーマシューティカルズ、インコーポレイテッド |
アセチルコリンエステラーゼ阻害剤と組み合わせた特定のα7ニコチン酸受容体を用いた認知障害の治療
|
CN102686595A
(zh)
|
2009-10-28 |
2012-09-19 |
百时美施贵宝公司 |
作为α-7 烟碱乙酰胆碱受体配体的氮杂二环化合物
|
US8278320B2
(en)
|
2009-10-28 |
2012-10-02 |
Bristol-Myers Squibb Company |
Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
US9833621B2
(en)
|
2011-09-23 |
2017-12-05 |
Setpoint Medical Corporation |
Modulation of sirtuins by vagus nerve stimulation
|
US11051744B2
(en)
|
2009-11-17 |
2021-07-06 |
Setpoint Medical Corporation |
Closed-loop vagus nerve stimulation
|
EP3636314B1
(en)
|
2009-12-23 |
2021-09-08 |
Setpoint Medical Corporation |
Neural stimulation devices and systems for treatment of chronic inflammation
|
EP2563796B1
(en)
|
2010-04-30 |
2015-03-18 |
Bristol-Myers Squibb Company |
Aza-bicyclic amine n-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs
|
ES2746850T3
(es)
|
2010-05-17 |
2020-03-09 |
Forum Pharmaceuticals Inc |
Formulaciones farmacéuticas que comprenden formas cristalinas de clorhidrato de (R)-7-cloro-N-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida monohidratado
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
GB201111704D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Novel compounds
|
JO3115B1
(ar)
|
2011-08-22 |
2017-09-20 |
Takeda Pharmaceuticals Co |
مركبات بيريدازينون واستخدامها كمثبطات daao
|
US9572983B2
(en)
|
2012-03-26 |
2017-02-21 |
Setpoint Medical Corporation |
Devices and methods for modulation of bone erosion
|
MX358512B
(es)
|
2012-05-08 |
2018-08-24 |
Forum Pharmaceuticals Inc |
Uso de (r)-7cloro-n-(quinuclidin-3-il) benzo[b] tiofeno-2-carboxamida o una sal farmacéuticamente aceptable de la misma para preparar una composición farmacéutica en el tratamiento de una disfunción cognitiva.
|
GB201209587D0
(en)
|
2012-05-30 |
2012-07-11 |
Takeda Pharmaceutical |
Therapeutic compounds
|
WO2014122474A1
(en)
|
2013-02-07 |
2014-08-14 |
Takeda Pharmaceutical Company Limited |
Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
|
CA2914263C
(en)
|
2013-06-21 |
2021-05-18 |
Takeda Pharmaceutical Company Limited |
1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
|
GB201314286D0
(en)
|
2013-08-08 |
2013-09-25 |
Takeda Pharmaceutical |
Therapeutic Compounds
|
GB201318222D0
(en)
|
2013-10-15 |
2013-11-27 |
Takeda Pharmaceutical |
Novel compounds
|
GB201320905D0
(en)
|
2013-11-27 |
2014-01-08 |
Takeda Pharmaceutical |
Therapeutic compounds
|
TW201613864A
(en)
|
2014-02-20 |
2016-04-16 |
Takeda Pharmaceutical |
Novel compounds
|
US11311725B2
(en)
|
2014-10-24 |
2022-04-26 |
Setpoint Medical Corporation |
Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
|
US11406833B2
(en)
|
2015-02-03 |
2022-08-09 |
Setpoint Medical Corporation |
Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
|
US10596367B2
(en)
|
2016-01-13 |
2020-03-24 |
Setpoint Medical Corporation |
Systems and methods for establishing a nerve block
|
US11471681B2
(en)
|
2016-01-20 |
2022-10-18 |
Setpoint Medical Corporation |
Batteryless implantable microstimulators
|
WO2017127758A1
(en)
|
2016-01-20 |
2017-07-27 |
Setpoint Medical Corporation |
Implantable microstimulators and inductive charging systems
|
WO2017127756A1
(en)
|
2016-01-20 |
2017-07-27 |
Setpoint Medical Corporation |
Control of vagal stimulation
|
US10583304B2
(en)
|
2016-01-25 |
2020-03-10 |
Setpoint Medical Corporation |
Implantable neurostimulator having power control and thermal regulation and methods of use
|
US10661112B2
(en)
|
2016-07-25 |
2020-05-26 |
Tonal Systems, Inc. |
Digital strength training
|
US11745039B2
(en)
|
2016-07-25 |
2023-09-05 |
Tonal Systems, Inc. |
Assisted racking of digital resistance
|
GB201616839D0
(en)
|
2016-10-04 |
2016-11-16 |
Takeda Pharmaceutical Company Limited |
Therapeutic compounds
|
GB201619514D0
(en)
|
2016-11-18 |
2017-01-04 |
Takeda Pharmaceuticals Co |
Novel compounds
|
WO2019036470A1
(en)
|
2017-08-14 |
2019-02-21 |
Setpoint Medical Corporation |
TESTING TEST FOR STIMULATION OF NERVE WAVE
|
US10335626B2
(en)
|
2017-10-02 |
2019-07-02 |
Tonal Systems, Inc. |
Exercise machine with pancake motor
|
US10617903B2
(en)
|
2017-10-02 |
2020-04-14 |
Tonal Systems, Inc. |
Exercise machine differential
|
US10589163B2
(en)
|
2017-10-02 |
2020-03-17 |
Tonal Systems, Inc. |
Exercise machine safety enhancements
|
US10486015B2
(en)
|
2017-10-02 |
2019-11-26 |
Tonal Systems, Inc. |
Exercise machine enhancements
|
US11660443B2
(en)
|
2018-04-20 |
2023-05-30 |
The Feinstein Institutes For Medical Research |
Methods and apparatuses for reducing bleeding via electrical trigeminal nerve stimulation
|
US11260229B2
(en)
|
2018-09-25 |
2022-03-01 |
The Feinstein Institutes For Medical Research |
Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
|
JP2021138648A
(ja)
|
2020-03-04 |
2021-09-16 |
武田薬品工業株式会社 |
経口固形製剤
|
US11938324B2
(en)
|
2020-05-21 |
2024-03-26 |
The Feinstein Institutes For Medical Research |
Systems and methods for vagus nerve stimulation
|
US11285355B1
(en)
|
2020-06-08 |
2022-03-29 |
Tonal Systems, Inc. |
Exercise machine enhancements
|
US11878204B2
(en)
|
2021-04-27 |
2024-01-23 |
Tonal Systems, Inc. |
First repetition detection
|